Our Healthcare sector is under-represented according to Portfolio Analytics. We do own VHI and are down, but most of what I read indicates a compelling case for VHI. As an example, National Bank Direct Brokerage rates it as outperform. Its current position is 0.76% of our Total Portfolio Equity Weight, and our only other sector holding (other than some diversified ETFs) is SIA with a Total Portfolio Equity Weight of 3.34%.
Q: Both of these name now represent 11% of a RRSP and about 9% of a total portfolio following steady and strong positive movement. Would you recommend selling 1 of these (about similar size)? Which one would it be? Thank you.
Q: Given the current Political/Fiscal/Demographic environment, I want to deploy funds to services that cater to seniors. The caveats are: 1) Taxable Account; 2) Cdn. $s; 3) To hold for 5+ years; and 4) Dividends of both seem reasonable, but are future prospects comparable, given relative financial strength and current governance? Thank you for your support and the questions from my fellow subscribers with your responses. Bill
I have a couple of questions about the noted companies - please deduct as you see fit.
I'm interested in dodging direct tariff risks, and it occurs to me that these two names fit that criterion because of their all Canadian business models. Do you think that conclusion is sensible?
Are there material differences between them leading to a clear favourite over the next 5 years? I note the SIA dividend is substantially larger than that of CSH, but would it be reasonable to assume this will be offset by greater share growth by CSH, over time?
And finally, would you consider one (or both) of them appropriate for a RRIF?
Thanks 5i - I look forward to your thoughts. Peter
Q: How do you think these companies will do during a recession or if Trump tariffs are introduced? Are they relatively tariff proofed?
Looking for some stability for the next few years with some income.
Q: I’ve always had less than positive results investing in the healthcare sector. Finally I decided to go with an ETF (XHC) to do away with the individual stock picking risk which has since declined as well. I am now thinking of sticking with “healthcare adjacent” companies since SIS (currently owned) has done well for me. Can you please comment on SIA, CSH, and AND, the first two have run up a bit recently and I wonder about their valuations and future prospects. Any other candidates that might fit the bill you could recommend, I know choices in Canada are slim?
Q: Have held Sienna for about 4 years, and despite some ups and downs, currently have some decent capital gains on top of the nice dividend. I have been considering selling it, but now notice there is a new issue. Could you comment on the purpose of the new issue and if you consider Sienna a hold or sell. This is in an RSP, so no tax implications.
Thank-you
Q: Hello 5i,
So, retired, dividend-oriented investor looking to add to Healthcare in Canada for a RRIF. Our primary healthcare holding is a full position in HHL, for the yield. P.A. indicates that we are overweight U.S. and need to increase our Canadian holding while healthcare is underweight.
We were considering CSH.UN, but it seems to be classed as a REIT (real estate is also overweight), so that doesn't seem to be an option. The 2 remaining choices seem to be either SIA or EXE, both seeming somewhat problematic.
Since the latest questions I could find on either SIA or EXE date back to last fall, could you update your analysis on these two equities with a view to whether either would be a suitable investment for us and whether the dividends appear safe for the foreseeable future?
And, finally, are there any other suitable Canadian healthcare options that pay a dividend?
Where there is nothing suitable in Canada, my thought was to return to ABBV and suck up the geographical imbalance. Thoughts?
As always, many thanks for your awesome service!!! It is very much appreciated!
Thanks,
Cheers,
Mike